LIAISON PLEX® Respiratory Flex Assay
Sample-to-Customizable Answers for Your Respiratory Algorithms
A multiplexed qualitative molecular test for the simultaneous detection and identification of up to 19 bacterial and viral targets, including SARS-CoV-2.
Want to learn more?
Sign up to receive the latest updates and insights about our new LIAISON PLEX® System.
Disease state
Respiratory tract infections involve a wide variety of etiologic agents and present with overlapping signs and symptoms. Prediction of the causative organism based on clinical findings alone is not reliable. The most frequent agents responsible for respiratory infections are viruses, followed by bacteria. Large respiratory panels for syndromic testing may not suit diverse seasonal, geographic, and patient-to-patient respiratory testing needs. A single comprehensive panel capable of bridging the gap between small and large panels by tailoring the number of pathogens reported is an ideal solution for clinical and cost-efficiencies to pay for only selected pathogens within the comprehensive panel.
Many respiratory pathogens present with the same clinical symptoms
The value of LIAISON PLEX® Respiratory Flex Assay
Customize your syndromic respiratory panel with one flexible solution.
Meets the needs of the dynamic post-pandemic respiratory landscape
Adapt to guidelines, unique testing algorithms, or the specific needs of patients and providers with a broad yet customizable respiratory panel.
Simplified workflow
Automated, multiplex, sample-to-answer system and all-in-one reagents for use on nasopharnygeal swabs.
The right assay design
Choice matters. Customize targets based on patient population and clinical symptoms. Pay only for those you choose.
How LIAISON PLEX® Respiratory Flex Assay works
LIAISON PLEX® Respiratory Flex Assay is a sample-to-answer, multiplexed in vitro diagnostic test for the detection and identification of respiratory disease-causing viruses and bacteria from patient samples, all in one self-contained cartridge.
Transfer sample
Transfer sample to cartridge.
Scan
Set up the run on the instrument. Scan the Sample ID and the Cartridge ID.
Load and run
Load the cartridge, initiate the Run, and walk away.
LIAISON PLEX® Respiratory Flex Assay
A broad range of targets that can be customizable to your patient population
Virus |
Virus |
Bacteria |
---|---|---|
Adenovirus |
Parainfluenza 1 |
Bordetella holmesii |
Human Coronavirus |
Parainfluenza 2 |
Bordetella parapertussis |
Human Metapneumovirus |
Parainfluenza 3 |
Bordetella pertussis |
Influenza A |
Parainfluenza 4 |
Chlamydia pneumoniae |
Influenza A (subtype H1) |
Rhinovirus/Enterovirus |
Mycoplasma pneumoniae |
Influenza A (subtype H3) |
RSV A/B |
|
Influenza B |
SARS-CoV-2 |
To be used on the LIAISON PLEX® System
The LIAISON PLEX® System is a next-generation, multiplex, sample-to-answer molecular diagnostic platform. Its proprietary Flex® Software enables users to pay only for required targets, with the option to customize results as needed.
LIAISON PLEX® Respiratory Flex Assay ordering info
Part Name |
Kit Size |
Registration Status |
Part Number |
---|---|---|---|
LIAISON PLEX® Respiratory Flex Assay |
12 |
IVD | 20-005-322 |
LIAISON PLEX® Flex Credits |
Multiples of 100 |
IVD | CN-0435-01 |